Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 218

    1.

    A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.

    Genç M, Mårdh A.

    Ann Intern Med. 1996 Jan 1;124(1 Pt 1):1-7.PMID: 7503471 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    An economic evaluation of screening for Chlamydia trachomatis in adolescent males.

    Genç M, Ruusuvaara L, Mårdh PA.

    JAMA. 1993 Nov 3;270(17):2057-64.PMID: 8411572 [PubMed - indexed for MEDLINE]Related articles

    3.

    Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.

    Howell MR, Gaydos JC, McKee KT Jr, Quinn TC, Gaydos CA.

    Sex Transm Dis. 1999 Oct;26(9):519-26.PMID: 10534206 [PubMed - indexed for MEDLINE]Related articles

    4.

    Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.

    Howell MR, Quinn TC, Brathwaite W, Gaydos CA.

    Sex Transm Dis. 1998 Feb;25(2):108-17.PMID: 9518379 [PubMed - indexed for MEDLINE]Related articles

    5.

    Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.

    Howell MR, Quinn TC, Gaydos CA.

    Ann Intern Med. 1998 Feb 15;128(4):277-84.PMID: 9471930 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.

    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.

    BJOG. 2004 Nov;111(11):1261-8.PMID: 15521872 [PubMed - indexed for MEDLINE]Related articles

    7.

    A school-based Chlamydia control program using DNA amplification technology.

    Cohen DA, Nsuami M, Etame RB, Tropez-Sims S, Abdalian S, Farley TA, Martin DH.

    Pediatrics. 1998 Jan;101(1):E1.PMID: 9417165 [PubMed - indexed for MEDLINE]Related articles

    8.

    Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.

    Lea AP, Lamb HM.

    Pharmacoeconomics. 1997 Nov;12(5):596-611. Review. Erratum in: Pharmacoeconomics 1998 Jun;13(6):696. PMID: 10174326 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.

    Nuovo J, Melnikow J, Paliescheskey M, King J, Mowers R.

    J Am Board Fam Pract. 1995 Jan-Feb;8(1):7-16.PMID: 7701965 [PubMed - indexed for MEDLINE]Related articles

    10.

    Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.

    Magid D, Douglas JM Jr, Schwartz JS.

    Ann Intern Med. 1996 Feb 15;124(4):389-99.PMID: 8554247 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings.

    Hillis SD, Coles FB, Litchfield B, Black CM, Mojica B, Schmitt K, St Louis ME.

    Sex Transm Dis. 1998 Jan;25(1):5-11.PMID: 9437777 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.

    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Jager HC, Coutinho RA.

    Value Health. 2001 May-Jun;4(3):266-75.PMID: 11705188 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chlamydia trachomatis: impact on human reproduction.

    Paavonen J, Eggert-Kruse W.

    Hum Reprod Update. 1999 Sep-Oct;5(5):433-47. Review.PMID: 10582782 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens.

    Guven MA, Gunyeli I, Dogan M, Ciragil P, Bakaris S, Gul M.

    Arch Gynecol Obstet. 2005 Sep;272(3):197-200. Epub 2005 Mar 19.PMID: 15778862 [PubMed - indexed for MEDLINE]Related articles

    16.

    Developments in the screening for Chlamydia trachomatis: a review.

    Kohl KS, Markowitz LE, Koumans EH.

    Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.PMID: 14719842 [PubMed - indexed for MEDLINE]Related articles

    17.

    Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.

    Nyári T, Nyári C, Woodward M, Mészáros G, Deák J, Nagy E, Kovács L.

    Acta Obstet Gynecol Scand. 2001 Apr;80(4):300-6.PMID: 11264602 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis.

    Genç M, Mårdh PA.

    Pharmacoeconomics. 1997 Sep;12(3):374-83.PMID: 10170462 [PubMed - indexed for MEDLINE]Related articles

    19.

    A decision analysis to guide antibiotic selection for Chlamydia infection during pregnancy.

    Hueston WJ, Lenhart JG.

    Arch Fam Med. 1997 Nov-Dec;6(6):551-5.PMID: 9371049 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.

    Haddix AC, Hillis SD, Kassler WJ.

    Sex Transm Dis. 1995 Sep-Oct;22(5):274-80.PMID: 7502180 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data